# Wheeler Bio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/wheeler-bio

- Industry: Biotechnology
- Headquarters: Oklahoma City, US
- Website: www.wheelerbio.com
- Total disclosed funding: $25M
- Latest round: Series A (Sep 16, 2022)
- Investors on record: 9

## About

Established in 2020 and based in Oklahoma, US, and founded by its CEO Dr.Jesse McCool, Wheeler Bio operates as a biomanufacturing company. In January 2022, Wheeler Bio raised USD 14 million in seed funding co-led by new investors Alloy Therapeutics, Inc. and Echo Investment Capital, with participation from other new investors FPG Inc. and Presbyterian Health Foundation. The company pilot labs are located inside Alloy Therapeutics’ Boston, MA Facility.

Wheeler Bio provides access to comprehensive discovery-to-IND programs with its rapid, high-quality biomanufacturing and Portable CMC™ platform that empowers preclinical CROs to halve the time to clinical supply for their customers, while significantly de-risking program onboarding for our CDMO partners.

The company will use the seed funding in the expansion of its team and access to Portable CMC services.

## Funding rounds

- Series A, Sep 16, 2022, $23M — Echo Investment Capital, Charles River Laboratories, Plains Venture Partners, Floating Point, Pine Ridge Advisers, DNA TwoPointO Inc.
- Seed, Nov 23, 2021, $1.5M — Echo Investment Capital, FPG Inc., Alloy Therapeutics, Inc., Presbyterian Health Foundation

## Investors

- Echo Investment Capital (https://capitalatlas.ai/funds/echo-investment-capital) — Seed, Series A
- FPG Inc. — Seed
- Alloy Therapeutics, Inc. — Seed
- Presbyterian Health Foundation — Seed
- Charles River Laboratories — Series A
- Plains Venture Partners (https://capitalatlas.ai/funds/plains-venture-partners) — Series A
- Floating Point (https://capitalatlas.ai/funds/floating-point) — Series A
- Pine Ridge Advisers — Series A
- DNA TwoPointO Inc. — Series A